Skip to main content

View full-text article in PMC

. 2013 May 28;19(20):3143–3149. doi: 10.3748/wjg.v19.i20.3143

Table 2.

Diagnostic value of circulating cell-free DNA, α-fetal protein and α L-fucosidase for hepatocellular carcinoma

Groups	Sensitivity	Specificity	Accuracy	Positive predictive value	Negative predictive value
cfDNA	56.4^c ^e	95.6^c ^e	77.4	91.7^c ^e	71.7
	(22/39)	(43/45)	(65/84)	(22/24)	(43/60)
AFP	53.8^c ^e	91.1^c ^e	73.8	84.0^e	69.5^c ^e
	(21/39)	(41/45)	(62/84)	(21/25)	(41/59)
AFU	66.7^e	75.6	71.4	70.3	72.3
	(26/39)	(34/45)	(60/84)	(26/37)	(34/47)
cfDNA + AFP	71.8^e	86.7^e	79.8	82.4	78
	(28/39)	(39/45)	(67/84)	(28/34)	(39/50)
cfDNA + AFU	87.2	71.1	78.6	72.3	86.5
	(34/39)	(32/45)	(66/84)	(34/47)	(32/37)
cfDNA + AFP + AFU	89.7^a	64.4^a	76.2	68.6	87.9
	(35/39)	(29/45)	(64/84)	(35/51)	(29/33)

^a

P < 0.05 vs group circulating cell-free DNA (cfDNA) + α-fetal protein (AFP);

^c

P < 0.05 vs group cfDNA + α L-fucosidase (AFU);

^e

P < 0.05 vs group cfDNA + AFP + AFU.